BACKGROUND AND PURPOSE: T16A(inh) -A01 is a recently identified inhibitor of the calcium-activated chloride channel TMEM16A. The aim of this study was to test the efficacy of T16A(inh) -A01 for inhibition of calcium-activated chloride channels in vascular smooth muscle and consequent effects on vascular tone. EXPERIMENTAL APPROACH: Single channel and whole cell patch clamp was performed on single smooth muscle cells from rabbit pulmonary artery and mouse thoracic aorta. Isometric tension studies were performed on mouse thoracic aorta and mesenteric artery as well as human abdominal visceral adipose artery. KEY RESULTS: In rabbit pulmonary artery myocytes T16A(inh) -A01 (1-30 μM) inhibited single calcium (Ca(2+) )-activated chloride (Cl(-) ) channels and whole cell currents activated by 500 nM free Ca(2+) . Similar effects were observed for single Ca(2+) -activated Cl(-) channels in mouse thoracic aorta, and in both cell types, channel activity was abolished by two antisera raised against TMEM16A but not by a bestrophin antibody. The TMEM16A potentiator, F(act) (10 μM), increased single channel and whole cell Ca(2+) -activated Cl(-) currents in rabbit pulmonary arteries. In isometric tension studies, T16A(inh) -A01 relaxed mouse thoracic aorta pre-contracted with methoxamine with an IC(50) of 1.6 μM and suppressed the methoxamine concentration-effect curve. T16A(inh) -A01 did not affect the maximal contraction produced by 60 mM KCl and the relaxant effect of 10 μM T16A(inh) -A01 was not altered by incubation of mouse thoracic aorta in a cocktail of potassium (K(+) ) channel blockers. T16A(inh) -A01 (10 μM) also relaxed human visceral adipose arteries by 88 ± 3%. CONCLUSIONS AND IMPLICATIONS: T16A(inh) -A01 blocks calcium-activated chloride channels in vascular smooth muscle cells and relaxes murine and human blood vessels.
BACKGROUND AND PURPOSE: T16A(inh) -A01 is a recently identified inhibitor of the calcium-activated chloride channel TMEM16A. The aim of this study was to test the efficacy of T16A(inh) -A01 for inhibition of calcium-activated chloride channels in vascular smooth muscle and consequent effects on vascular tone. EXPERIMENTAL APPROACH: Single channel and whole cell patch clamp was performed on single smooth muscle cells from rabbit pulmonary artery and mouse thoracic aorta. Isometric tension studies were performed on mouse thoracic aorta and mesenteric artery as well as human abdominal visceral adipose artery. KEY RESULTS: In rabbit pulmonary artery myocytes T16A(inh) -A01 (1-30 μM) inhibited single calcium (Ca(2+) )-activated chloride (Cl(-) ) channels and whole cell currents activated by 500 nM free Ca(2+) . Similar effects were observed for single Ca(2+) -activated Cl(-) channels in mouse thoracic aorta, and in both cell types, channel activity was abolished by two antisera raised against TMEM16A but not by a bestrophin antibody. The TMEM16A potentiator, F(act) (10 μM), increased single channel and whole cell Ca(2+) -activated Cl(-) currents in rabbit pulmonary arteries. In isometric tension studies, T16A(inh) -A01 relaxed mouse thoracic aorta pre-contracted with methoxamine with an IC(50) of 1.6 μM and suppressed the methoxamine concentration-effect curve. T16A(inh) -A01 did not affect the maximal contraction produced by 60 mM KCl and the relaxant effect of 10 μM T16A(inh) -A01 was not altered by incubation of mouse thoracic aorta in a cocktail of potassium (K(+) ) channel blockers. T16A(inh) -A01 (10 μM) also relaxed human visceral adipose arteries by 88 ± 3%. CONCLUSIONS AND IMPLICATIONS: T16A(inh) -A01 blocks calcium-activated chloride channels in vascular smooth muscle cells and relaxes murine and human blood vessels.
Authors: Normand Leblanc; Jonathan Ledoux; Sohag Saleh; Amy Sanguinetti; Jeff Angermann; Kate O'Driscoll; Fiona Britton; Brian A Perrino; Iain A Greenwood Journal: Can J Physiol Pharmacol Date: 2005-07 Impact factor: 2.273
Authors: S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood Journal: Br J Pharmacol Date: 2007-05-21 Impact factor: 8.739
Authors: Vladimir V Matchkov; Per Larsen; Elena V Bouzinova; Aleksandra Rojek; Donna M Briggs Boedtkjer; Veronika Golubinskaya; Finn Skou Pedersen; Christian Aalkjaer; Holger Nilsson Journal: Circ Res Date: 2008-09-05 Impact factor: 17.367
Authors: Stephen Fedigan; Eamonn Bradley; Timothy Webb; Roddy J Large; Mark A Hollywood; Keith D Thornbury; Noel G McHale; Gerard P Sergeant Journal: Pflugers Arch Date: 2017-07-21 Impact factor: 3.657
Authors: Ramon J Ayon; Matthew B Hawn; Joydeep Aoun; Michael Wiwchar; Abigail S Forrest; Fiona Cunningham; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc Journal: Am J Physiol Cell Physiol Date: 2019-08-28 Impact factor: 4.249
Authors: Amal K Dutta; Kangmee Woo; Al-karim Khimji; Charles Kresge; Andrew P Feranchak Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-10-25 Impact factor: 4.052
Authors: Henry R Askew Page; Thomas Dalsgaard; Samuel N Baldwin; Thomas A Jepps; Oleksandr Povstyan; Søren P Olesen; Iain A Greenwood Journal: Br J Pharmacol Date: 2019-04-11 Impact factor: 8.739
Authors: Tae Sik Sung; Kate O'Driscoll; Haifeng Zheng; Nicholas J Yapp; Normand Leblanc; Sang Don Koh; Kenton M Sanders Journal: Am J Physiol Cell Physiol Date: 2016-07-13 Impact factor: 4.249
Authors: Abigail S Forrest; Talia C Joyce; Marissa L Huebner; Ramon J Ayon; Michael Wiwchar; John Joyce; Natalie Freitas; Alison J Davis; Linda Ye; Dayue D Duan; Cherie A Singer; Maria L Valencik; Iain A Greenwood; Normand Leblanc Journal: Am J Physiol Cell Physiol Date: 2012-10-03 Impact factor: 4.249